A detailed history of Wbh Advisory Inc transactions in Pfizer Inc stock. As of the latest transaction made, Wbh Advisory Inc holds 17,952 shares of PFE stock, worth $477,882. This represents 0.05% of its overall portfolio holdings.

Number of Shares
17,952
Previous 23,939 25.01%
Holding current value
$477,882
Previous $669,000 22.42%
% of portfolio
0.05%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$27.7 - $31.39 $165,839 - $187,931
-5,987 Reduced 25.01%
17,952 $519,000
Q2 2024

Jul 11, 2024

SELL
$25.26 - $29.6 $97,831 - $114,640
-3,873 Reduced 13.93%
23,939 $669,000
Q1 2024

Apr 16, 2024

SELL
$25.89 - $29.73 $144,388 - $165,804
-5,577 Reduced 16.7%
27,812 $771,000
Q4 2023

Jan 09, 2024

SELL
$26.13 - $33.94 $55,160 - $71,647
-2,111 Reduced 5.95%
33,389 $961,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $101,147 - $118,231
-3,152 Reduced 8.15%
35,500 $1.18 Million
Q2 2023

Jul 12, 2023

SELL
$36.12 - $41.79 $85,423 - $98,833
-2,365 Reduced 5.77%
38,652 $1.42 Million
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $76,022 - $98,970
1,930 Added 4.94%
41,017 $1.67 Million
Q3 2022

Oct 18, 2022

SELL
$43.76 - $53.42 $26,868 - $32,799
-614 Reduced 1.55%
39,087 $1.71 Million
Q2 2022

Jul 12, 2022

SELL
$46.53 - $55.17 $3,908 - $4,634
-84 Reduced 0.21%
39,701 $2.1 Million
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $114,192 - $141,498
-2,496 Reduced 5.9%
39,785 $2.06 Million
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $17,726 - $26,276
429 Added 1.03%
42,281 $2.5 Million
Q3 2021

Oct 25, 2021

BUY
$39.25 - $50.42 $19,782 - $25,411
504 Added 1.22%
41,852 $1.8 Million
Q2 2021

Jul 27, 2021

SELL
$35.91 - $40.68 $104,749 - $118,663
-2,917 Reduced 6.59%
41,348 $1.73 Million
Q1 2021

Apr 19, 2021

SELL
$33.49 - $37.77 $55,593 - $62,698
-1,660 Reduced 3.61%
44,265 $1.6 Million
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $29,085 - $36,984
869 Added 1.93%
45,925 $1.68 Million
Q3 2020

Oct 27, 2020

SELL
$31.75 - $37.25 $3,556 - $4,172
-112 Reduced 0.25%
45,056 $1.65 Million
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $41,113 - $49,877
-1,365 Reduced 2.93%
45,168 $1.48 Million
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $112,390 - $160,581
-4,158 Reduced 8.2%
46,533 $1.52 Million
Q4 2019

Jan 27, 2020

SELL
$32.92 - $37.36 $9,645 - $10,946
-293 Reduced 0.57%
50,691 $1.99 Million
Q3 2019

Oct 25, 2019

BUY
$32.49 - $42.13 $28,623 - $37,116
881 Added 1.76%
50,984 $1.83 Million
Q2 2019

Aug 02, 2019

SELL
$36.98 - $41.52 $93,115 - $104,547
-2,518 Reduced 4.79%
50,103 $2.17 Million
Q1 2019

Apr 22, 2019

SELL
$37.5 - $41.2 $84,900 - $93,276
-2,264 Reduced 4.12%
52,621 $2.23 Million
Q4 2018

Jan 29, 2019

SELL
$38.47 - $43.86 $5,655 - $6,447
-147 Reduced 0.27%
54,885 $2.4 Million
Q3 2018

Oct 29, 2018

BUY
$34.47 - $41.81 $18,096 - $21,950
525 Added 0.96%
55,032 $2.43 Million
Q2 2018

Jul 31, 2018

BUY
$32.98 - $35.16 $6,991 - $7,453
212 Added 0.39%
54,507 $1.98 Million
Q1 2018

Apr 30, 2018

SELL
$31.91 - $37.02 $23,581 - $27,357
-739 Reduced 1.34%
54,295 $1.93 Million
Q4 2017

Jan 31, 2018

SELL
$33.26 - $35.29 $56,741 - $60,204
-1,706 Reduced 3.01%
55,034 $1.99 Million
Q3 2017

Nov 29, 2017

BUY
$31.0 - $34.15 $1.76 Million - $1.94 Million
56,740
56,740 $2.03 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wbh Advisory Inc Portfolio

Follow Wbh Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbh Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wbh Advisory Inc with notifications on news.